Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07064200 · ClinicalTrials.gov registry record · NA

TAP Block Timing Study

A NA study of Bariatric Surgery Patients and Bariatric or General Abdominal Surgeries, sponsored by Weill Medical College of Cornell University.

Recruiting
Registry status
NA
Development phase
150
Enrollment target
1
Study location

NCT07064200 is a NA study of Bariatric Surgery Patients and Bariatric or General Abdominal Surgeries that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 150 participants, above the 93-participant average among 3 other Bariatric Surgery Patients trials with a reported enrollment target (61% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07064200, a NA study of Bariatric Surgery Patients and Bariatric or General Abdominal Surgeries, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.

RECRUITING
Registry status
NA
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

This study investigates whether administering TAP blocks pre-incision provides superior postoperative pain control and reduces opioid use along with other medications compared to post-incision administration in patients undergoing elective abdominal surgeries.

Interventions

  • OTHER TAP Block

Study Locations (1)

New York

  • Weill Cornell Medical College - NewYork-Presbyterian Hospital - New York

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2025-07-14
Est. Completion 2027-07
Phase NA

What the Registry Record Tells You About NCT07064200

The ClinicalTrials.gov registry entry for NCT07064200 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 93-participant average among 3 other Bariatric Surgery Patients trials with a reported enrollment target (61% higher). The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Bariatric Surgery Patients appearing as the primary indexed condition, and to 1 intervention - of which TAP Block is the first listed.

NCT07064200 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT07064200 about?

NCT07064200 is a clinical study titled "TAP Block Timing Study". This study investigates whether administering TAP blocks pre-incision provides superior postoperative pain control and reduces opioid use along with other medications compared to post-incision administration in patients undergoing elective abdominal surgeries.

What is the current status of trial NCT07064200?

This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2025-07-14. Estimated completion is 2027-07.

What conditions does trial NCT07064200 study?

This clinical trial studies the following conditions: Bariatric Surgery Patients, Bariatric or General Abdominal Surgeries.

What interventions are being tested in trial NCT07064200?

The interventions under investigation include: TAP Block (OTHER).

Who is sponsoring clinical trial NCT07064200?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07064200 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Bariatric Surgery Patients

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.